---
title: "Weekly Recap | Unitedhealth +1.07%, most brokers rate it buy"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298103874.md"
description: "UnitedHealth (UNH) closed the week at $397.14, up 1.07%, while the S&P 500 gained 0.09%, leaving UNH roughly 0.98 percentage points ahead of the benchmark. The price pattern was choppy to start and firmer later: Monday opened lower with an intraday low of $387.71, then Tuesday through Thursday pushed higher, reaching a high of $405.16 on Thursday before a pullback to $397.14 on Friday. The close sits above the 20-day moving average of $396."
datetime: "2026-09-05T08:26:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298103874.md)
  - [en](https://longbridge.com/en/news/298103874.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298103874.md)
generator: "portal-rs"
---

# Weekly Recap | Unitedhealth +1.07%, most brokers rate it buy

## The Week

UnitedHealth (UNH) closed the week at $397.14, up 1.07%, while the S&P 500 gained 0.09%, leaving UNH roughly 0.98 percentage points ahead of the benchmark. The price pattern was choppy to start and firmer later: Monday opened lower with an intraday low of $387.71, then Tuesday through Thursday pushed higher, reaching a high of $405.16 on Thursday before a pullback to $397.14 on Friday. The close sits above the 20-day moving average of $396.912 but still below the 60-day average of $410.957, so the shorter-term trend has improved while the medium-term picture remains softer.

## Key Events

The week’s main story was a pullback in prior authorization requirements. On 1 September, UnitedHealthcare said it would drop prior authorization for a range of conditions from 1 October. The next day, the company clarified that roughly 30% of services would see prior authorization removed, and announced a rural prior authorization waiver programme for eligible rural hospitals and affiliated providers starting on 1 November. The stock rallied on 2 September as the news landed. Separately, Van ECK Associates Corp disclosed a lower position in UNH, which is an individual portfolio move rather than a company development. Overall, the narrative was about simplifying care management, not earnings or regulation.

## Analyst Ratings

Across 27 covering institutions, 16 rate the stock buy, 7 rate it over, and 4 rate it hold, with no under or sell ratings. The consensus recommendation is buy, with a consensus target of $475.23077, implying about 19.66% upside from the latest price. Targets range from $313 to $529, a wide spread that points to meaningful disagreement. Within the managed healthcare industry, UNH ranks first out of nine names.

## The Week Ahead

Next week’s macro and inflation data cluster on Thursday, 10 September: final demand PPI, core PPI, initial jobless claims, existing home sales, and the 10-year Treasury auction all land that day. For a healthcare heavyweight like UNH, PPI and rate moves could influence how the sector trades relative to the broader market. The NFIB Small Business Optimism Index on Tuesday, 8 September is an earlier read on activity. There are no obvious company-level earnings events on the calendar.

## In Short

This week’s rally coincided with the company’s move to simplify prior authorization, but the link is correlation more than established causation. The analyst picture leans constructive, with a consensus target about 20% above spot, though the wide target range shows a lack of agreement on how far the stock can go. On the latest trading day, large-lot money turned net outflow while smaller orders were more active, but that is only a single-day snapshot. The watchpoints now are how PPI and rates affect healthcare, and whether the waiver programme translates into a more durable re-rating.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [UNH.US](https://longbridge.com/en/quote/UNH.US.md)
- [UNHU.US](https://longbridge.com/en/quote/UNHU.US.md)
- [UNHG.US](https://longbridge.com/en/quote/UNHG.US.md)
- [UNHW.US](https://longbridge.com/en/quote/UNHW.US.md)

## Related News & Research

- [Axuall appoints Optum, Change Healthcare veteran Kris Joshi to board](https://longbridge.com/en/news/298758291.md)
- [BUZZ-'Cut points' for 2027 Medicare Advantage plans look neutral to positive, analysts say](https://longbridge.com/en/news/298494594.md)
- [EXCLUSIVE-TPG explores $5 billion sale of healthcare software company Lyric, sources say](https://longbridge.com/en/news/298497579.md)
- [Harmony Biosciences Chief Medical Officer Sold Shares Worth Over $1.4M](https://longbridge.com/en/news/298506671.md)
- [UnitedHealthcare's Rural Prior Authorization Waiver Program For Eligible Rural Hospitals & Affiliated Providers To Begin Nov 1](https://longbridge.com/en/news/297624860.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**